Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tshetiz Dahal

General Physician, Lugansk State Medical University, Luhansk Oblast, 93000 Luhansk, Ukraine
Publications

Immuno-Therapy in Lung Cancer - How Does Immuno-Therapy For Lung Cancer Change Patients' Vision?

Survival rates of metastatic lung cancer including non-small cell lung cancer (NSCLC) and poor lung cell cancer (SCLC) are poor with a survival rate of less than 5%. The use of cell-oriented therapies has improved the overall survival of the median (OS) in a limited group of NSCLC patients whose tumors undergo certain genetic mutations. However in ... Read More»

Tshetiz Dahal

: J Cancer Diagn 2022, 6:140

10.4172/2476-2253.1000140

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Relevant Topics
Top